Aurora Cannabis Inc. - Common Shares (ACB)
5.7300
-0.2300 (-3.86%)
NASDAQ · Last Trade: Oct 2nd, 2:39 AM EDT
Detailed Quote
| Previous Close | 5.960 |
|---|---|
| Open | 5.950 |
| Bid | 5.720 |
| Ask | 5.780 |
| Day's Range | 5.720 - 5.950 |
| 52 Week Range | 3.422 - 6.910 |
| Volume | 1,569,284 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 1,600,372 |
Chart
About Aurora Cannabis Inc. - Common Shares (ACB)
Aurora Cannabis Inc. is a leading company in the cannabis industry, primarily focused on the production and distribution of medical and recreational cannabis products. With a commitment to sustainability and innovation, the company cultivates a diverse range of cannabis strains and products, including dried flower, oils, and edibles, aimed at meeting the demands of consumers and patients alike. Aurora operates through a network of facilities and has established a strong presence in multiple international markets, working to advance the understanding and benefits of cannabis through research and development. The company is dedicated to promoting responsible usage and prioritizes quality and compliance within its operations. Read More
News & Press Releases
President Trump's social media feed put the markets in a frenzy.
Via The Motley Fool · October 1, 2025
U.S. markets kicked off the week quietly, but certain stocks were anything but dull. Cannabis names surged after a Trump-endorsed CBD video went viral, while biotech firm MoonLake was crushed by disastrous trial results. Meanwhile, macro tension builds with a potential U.S. government shutdown and Friday’s key jobs report looming.
Via Chartmill · September 30, 2025
President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in federal drug policy.
Via Benzinga · September 29, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · September 29, 2025
420 with CNW — US Congressional Committee to Conduct Hearing This Week on Illegal Chinese Cannabis Operations
A Republican-led committee in Congress is set to hold a hearing on what some lawmakers are calling a Chinese “invasion” of the United States through illegal cannabis operations.
Via CannabisNewsWire · September 18, 2025
420 with CNW — US Congressional Committee to Conduct Hearing This Week on Illegal Chinese Cannabis Operations
A Republican-led committee in Congress is set to hold a hearing on what some lawmakers are calling a Chinese “invasion” of the United States through illegal cannabis operations.
Via Investor Brand Network · September 18, 2025
420 with CNW — US Congressmen Reintroduce Comprehensive Cannabis Reform Bill
Congress could finally advance a measure to legalize cannabis federally this legislative session. Representatives Jerrold Nadler, Ilhan Omar, Nydia Velázquez, and Dina Titus have once again put forward the MORE Act . The measure is one of the most far-reaching pieces of cannabis reform ever introduced in Congress.
Via Investor Brand Network · September 3, 2025
420 with CNW — US Congressmen Reintroduce Comprehensive Cannabis Reform Bill
Congress could finally advance a measure to legalize cannabis federally this legislative session. Representatives Jerrold Nadler, Ilhan Omar, Nydia Velázquez, and Dina Titus have once again put forward the MORE Act . The measure is one of the most far-reaching pieces of cannabis reform ever introduced in Congress.
Via CannabisNewsWire · September 3, 2025
420 with CNW — New York’s Cannabis Social Equity Program Faces Another Legal Challenge
New York’s cannabis industry faced another setback recently after a federal appeals court ruled that the state unlawfully discriminated against applicants from outside New York in a recent licensing process.
Via Investor Brand Network · August 19, 2025
420 with CNW — New York’s Cannabis Social Equity Program Faces Another Legal Challenge
New York’s cannabis industry faced another setback recently after a federal appeals court ruled that the state unlawfully discriminated against applicants from outside New York in a recent licensing process.
Via CannabisNewsWire · August 19, 2025
Tilray stock surged 14.13% after hours as reports of a possible marijuana reclassification by Trump fueled investor optimism.
Via Benzinga · August 12, 2025
Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that President Trump is considering reclassifying marijuana as a less dangerous drug.
Via Benzinga · August 11, 2025
Retail Bulls Pile Into Cannabis Stocks On Reports Trump May Reclassify Marijuana; Traders Eye Aurora Rallystocktwits.com
Via Stocktwits · August 11, 2025
Aurora Cannabis Q1 FY26 earnings call transcript
Via Benzinga · August 6, 2025
420 with CNW — Georgia Lawmakers Weigh Conflicting Proposals on Marijuana and Hemp Reforms
Georgia lawmakers are reviewing the future of hemp and marijuana products in the state, and opinions are sharply divided. During a recent legislative study committee meeting, people from both sides of the debate shared their experiences and concerns, laying the groundwork for possible policy updates in the state.
Via CannabisNewsWire · August 4, 2025
420 with CNW — Georgia Lawmakers Weigh Conflicting Proposals on Marijuana and Hemp Reforms
Georgia lawmakers are reviewing the future of hemp and marijuana products in the state, and opinions are sharply divided. During a recent legislative study committee meeting, people from both sides of the debate shared their experiences and concerns, laying the groundwork for possible policy updates in the state.
Via Investor Brand Network · August 4, 2025
420 with CNW — Calls to Regulate THC in Marijuana Products Grow in Canada
Emergency rooms across Canada are seeing a significant increase in visits from marijuana users suffering from repeated, severe vomiting—a condition called cannabis hyperemesis syndrome (CHS). According to a recent study, cases of CHS have grown thirteenfold over an eight-year period, making up over 8,000 of nearly 13,000 marijuana-related ER visits during that time.
Via Investor Brand Network · July 18, 2025
420 with CNW — Calls to Regulate THC in Marijuana Products Grow in Canada
Emergency rooms across Canada are seeing a significant increase in visits from marijuana users suffering from repeated, severe vomiting—a condition called cannabis hyperemesis syndrome (CHS). According to a recent study, cases of CHS have grown thirteenfold over an eight-year period, making up over 8,000 of nearly 13,000 marijuana-related ER visits during that time.
Via CannabisNewsWire · July 18, 2025
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the “Company”) (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 6, 2025
420 with CNW — Poll Finds Most Texas Voters Oppose Banning Hemp Products
A new poll shows that most Texas voters are not in favor of a full ban on hemp-based THC products. The survey revealed that 53% of voters were against the ban that state lawmakers had passed under SB 3. In contrast, just 31% said they were in favor of it.
Via Investor Brand Network · July 2, 2025
420 with CNW — Poll Finds Most Texas Voters Oppose Banning Hemp Products
A new poll shows that most Texas voters are not in favor of a full ban on hemp-based THC products. The survey revealed that 53% of voters were against the ban that state lawmakers had passed under SB 3. In contrast, just 31% said they were in favor of it.
Via CannabisNewsWire · July 2, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the “Company”) (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 1, 2025
NEW YORK CITY, NY / ACCESS Newswire / June 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ:ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Via ACCESS Newswire · June 30, 2025